Intraoperative cell-salvaged versus allogeneic red blood cell transfusions in high-bleeding-risk cardiovascular surgery: Protocol for a single-center, randomized, parallel-group, noninferiority trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0334397 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Akito Tsukinaga und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Blood Loss, Surgical, Cardiovascular Surgical Procedures, Erythrocyte Transfusion, Operative Blood Salvage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cerebral and Cardiovascular Center.
Abstract (Originalsprache)
Introduction
Patients who undergo cardiac surgery have a high risk of significant blood loss and anemia. While allogeneic red blood cell (RBC) transfusions are effective, they are associated with increased morbidity and mortality. Intraoperative cell salvage may reduce reliance on allogeneic transfusions. Although intraoperative RBC salvage is recommended for cardiovascular surgery under cardiopulmonary bypass, there are concerns about increased bleeding due to coagulopathy in patients with a high bleeding risk, and its clinical impact remains unclear. This study aims to evaluate whether salvaged RBC transfusion is noninferior to allogeneic transfusion in terms of postoperative blood loss in patients with a high bleeding risk.
Methods
This single-center, randomized, two-arm, parallel group, interventional clinical trial will include 142 participants aged ≥ 40 years with a high bleeding risk who undergo elective cardiovascular surgery with cardiopulmonary bypass. Participants will be randomly assigned to receive either salvaged RBC or allogeneic RBC transfusions intraoperatively. The primary outcome is postoperative chest tube blood loss within 12 hours from the end of surgery. Noninferiority will be demonstrated if the upper limit of the 95% confidence interval for the mean difference in blood loss between the salvaged and allogeneic groups is < 200 mL. Secondary outcomes comprise the RBC transfusion volume intraoperatively and for 12 hours from the end of surgery, prevalence of re-thoracotomy within 48 hours from the end of surgery, and prevalence of ≥ 1000 mL postoperative chest tube blood loss within 12 hours from the end of surgery. These outcomes will be analyzed using the modified intention-to-treat set and repeated, for sensitivity reasons, for the per-protocol set.
Discussion
Our trial aims to determine the noninferiority of intraoperative RBC salvage compared with allogeneic blood transfusions regarding postoperative blood loss and to promote its use in surgical procedures with a high bleeding risk.
Trial registration
The trial was registered with the Japan Registry of Clinical Trials (jRCT1052240102) on July 30, 2024.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anesthesiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Transfusion, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Kanagawa, Japan.
- Department of Anesthesiology, Yokohama City University School of Medicine, Yokohama, Kanagawa, Japan.
- Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
ORCID-Profile: Akito Tsukinaga, Kenji Yoshitani, Takahiro Mihara, Takuma Maeda
Förderung
- National Cerebral and Cardiovascular Center
Zitieren
APA
Tsukinaga, A., Yoshitani, K., Ogata, S., Mihara, T., Ito, S., Kanazawa, H., Shimokawa, A., Masuda, S., Morinaga, M., Ito, Y., Miura, S., Kawamoto, N., Inoue, Y., Fukushima, S., Matsuda, H., & Maeda, T. (2025). Intraoperative cell-salvaged versus allogeneic red blood cell transfusions in high-bleeding-risk cardiovascular surgery: Protocol for a single-center, randomized, parallel-group, noninferiority trial. PLOS One. https://doi.org/10.1371/journal.pone.0334397
Vancouver
Tsukinaga A, Yoshitani K, Ogata S, Mihara T, Ito S, Kanazawa H, et al. Intraoperative cell-salvaged versus allogeneic red blood cell transfusions in high-bleeding-risk cardiovascular surgery: Protocol for a single-center, randomized, parallel-group, noninferiority trial. PLOS One. 2025. doi:10.1371/journal.pone.0334397
BibTeX
@article{Tsukinaga2025,
author = {Tsukinaga, Akito and Yoshitani, Kenji and Ogata, Soshiro and Mihara, Takahiro and Ito, Shin and Kanazawa, Hiroko and Shimokawa, Akira and Masuda, Sho and Morinaga, Masahiro and Ito, Yoshiaki and Miura, Shinnosuke and Kawamoto, Naonori and Inoue, Yosuke and Fukushima, Satsuki and Matsuda, Hitoshi and Maeda, Takuma},
title = {Intraoperative cell-salvaged versus allogeneic red blood cell transfusions in high-bleeding-risk cardiovascular surgery: Protocol for a single-center, randomized, parallel-group, noninferiority trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0334397}
}
EUVIMED